Researchers have developed a method to program immune cells to target glioblastoma and reduce inflammation associated with multiple sclerosis in mice. This technology is set to undergo clinical trials in humans for glioblastoma treatment. UCSF scientists have developed a “molecular GPS” to direct immune cells into the brain, enabling them to target and eliminate tumors […]
Source link